Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?
Lesage
S
S
INSERM UMR 679 (former U289), Hôpital de la Salpêtrière, Paris Cedex 13, France.
Belarbi
S
S
Troiano
A
A
Condroyer
C
C
Hecham
N
N
Pollak
P
P
Lohman
E
E
Benhassine
T
T
Ysmail-Dahlouk
F
F
Dürr
A
A
Tazir
M
M
Brice
A
A
D000293:Adolescent; D000328:Adult; D000352:Africa, Northern; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D020820:Dyskinesias / Q000235:genetics*; D005260:Female; D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000235:genetics* / Q000503:physiopathology; D017354:Point Mutation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*
C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases